Apero Health

Consider what happens when you visit a doctor. You are seen, you are treated, and then a second, invisible transaction begins - one you never watch. A code is chosen. A claim is built. It goes to an insurer, which may pay it, deny it, or sit on it. Somewhere a person appeals, resubmits, reconciles a bank deposit that does not match the statement. This is the revenue cycle, and for most practices it is a slow, expensive leak that nobody enjoys and everybody tolerates.

Apero Health, founded in San Francisco in 2019 and backed by Y Combinator's Summer 2019 batch, decided the tolerating was the opportunity. The company's tagline - "healthcare software for innovators" - undersells the thing a bit. What Apero actually sells is the unglamorous middle of a medical practice: scheduling, visit notes, insurance billing, real-time eligibility, patient statements, e-prescriptions, and the financial reporting that tells a clinic whether it is, in fact, making money.

The origin is small and specific, which is usually a good sign. The idea traces back to a founder's mother's medical practice in Washington, DC, that struggled to get paid on time. That is the kind of detail investors like, because it means the founders felt the problem before they modeled it. You do not accidentally build claim-validation rules. You build them because a denial cost someone you know real money.

The pitch is speed and transparency in an industry that has historically offered neither. Apero claims implementation in under a day, billing time cut by as much as 80%, and payer enrollment across all 50 states - averaging around 12 days for ERA enrollment. Those are operational numbers, not marketing numbers, and they are the kind a practice manager can check against their own calendar. In healthcare software, that is roughly the highest compliment you can pay a product.

What is quietly interesting about Apero is the shape of the company. By mid-2024, public reporting put it at roughly $5 million in annual revenue on a team of about fourteen people. That is not a rocket ship in the venture sense; it is something rarer and arguably harder - a lean software business in a regulated market that most engineers would rather not touch. Roughly $350,000 of revenue per employee, generated by making claims go through.

The team explains the ambition. Apero was built, in part, by former engineers from Doctor On Demand, the National Security Agency, MIT, Stanford, and Berkeley, alongside AAPC-certified medical coders. The NSA lineage is not a party trick - it shows up as SOC 2 Type 2 certification, HIPAA compliance, encryption, audit logging, and provider SSO. When your product touches both protected health information and money, "we take security seriously" needs to be a line item, not a slogan. Apero appears to treat it that way.

The differentiation is mostly about denials, which is where practices actually lose money. Rather than fight rejections after the fact, Apero uses custom validation rules and machine learning on denial codes to catch problems before a claim is ever submitted. It is a small philosophical stance with large financial consequences: prevention beats appeals, and software is very good at prevention if you point it at the right patterns.

And then there is the developer story, which is where the "for innovators" tagline earns its keep. Apero exposes an API, webhooks, CSV import, and custom worklists, which means digital health companies can wire scheduling, eligibility, and billing directly into their own products. It is the difference between selling a tool and selling a platform - and it is why Apero's customer list reads like a roster of behavioral and digital health companies rather than only traditional clinics.